The first FDA approved 3D printed pharmaceutical is an epilepsy drug produced by Aprecia Pharmaceuticals Company (“Aprecia”). In its press release, Aprecia noted that the epilepsy drug, called Spritam® levetiracetam, has been approved for oral use to treat partial onset seizures, myoclonic seizures... read more
        This Episode is about 3D printing and copyright law, but in case you missed it, first check out 3D print Wars: Episode I to learn about 3D printing in general.     For years, Warhammer tabletop gamers have sculpted and painted miniatures (... read more
          September 5, 2012, the 2nd Circuit Court of Appeals came to a decision regarding one of the most closely watched cases in trademark law, Christian Louboutin v. Yves Saint Laurent. The Court of Appeals reversed the lower court decision which stated that a... read more
Three British universities recently proposed an interesting initiative called the Easy Access IP Project. The goal is to grant royalty-free licenses to anyone willing to commercialize technology within the university’s portfolio that has not yet been commercialized. Most licenses are non-exclusive... read more
As reported by Gamezone on January 4, a new rumor has surfaced about the development of the next generation Xbox, or Xbox 720 – a clever twist on the current Xbox 360 title, due to a patent recently granted to Microsoft.  United States Patent No. 8,083,593 was issued on December 27, 2011, and... read more
The world of passwords for electronic devices is on the brink of extinction if Apple, Inc. (Apple) is able to effectively develop its latest published patent application. On December 29, 2011, the USPTO published US Patent Application 2011/0317872 entitled, “Low Threshold Face Recognition”  ... read more
You are no doubt on the edge of your seat waiting to see what other changes are in store if the Patent Reform Act of 2007 is enacted.  Well, wait no longer, this blog post brings to you not one, but two more proposed changes to the current Patent System:  (1) Prior User Rights and (2... read more
Check out this week’s WAR OF THE WORDS: Businessweek reports that in Beijing, China, a pharmaceutical company was refused permission to use the name of a disgraced official as a trademark to sell rat poison. Forbes reports that Jimi Hendrix’s sister, Janie Hendrix, is suing a Seattle... read more
Help!  I know the erudite readers of PHOSITA may have valuable information I need: I am working on article regarding the makeup of corporate board of directors and I am trying to get a sense of how many patent attorneys are directors. If you know of anyone or have a suspicion, please send it... read more
First off, does anyone know how to say “Grande Soy Latte with Sugar-Free Hazelnut” in Korean? On Wednesday, South Korea’s patent court ruled against Starbucks in a trademark infringement suit against Elpreya. Elpreya, a Seoul-based company, was established in 1999 and operates... read more
A couple of weeks ago, the IP Section of the Oklahoma Bar Association conducted its annual CLE seminar at Tanglewood Resort on Lake Texoma.  My partner, Nick Rouse, was in charge of the weekend and did a phenomenal job. The lecturers were top notch and although I am a bit biased, I would have... read more
US inventors/applications appear to be cautiously extending the number of patent applications they are filing in China. BEIJING, Feb. 15 (Xinhuanet) -- The amount of U.S. patent applications to China reached 20,395 in 2005, a year-on-year increase of 30 percent, Li Yuguang, deputy director of... read more
Looks like things are beginning to heat up in the intellectual property insurance marketplace in India. India Inc does not seem to be very familiar with patent insurance, which provides protection against infringement of patents and associated costs. That is because none of the insurance... read more
Welcome to the 121st edition of Carnival of the Capitalists! We here are known as PHOSITA (pho – see – tah) : an arcane bit of patentese that refers to the mythical person of ordinary skill in the art.  If an invention is obvious to PHOSITA, you are SOL and will not be able to... read more
You know the old saying… save the best for last.  It is my utmost pleasure to be able to finally and “officially” announce that J. Matthew Buchanan has joined Dunlap Codding & Rogers, P.C.  I know that others (including Matt, Steve, Dennis and Kevin, among many... read more